Back to search

Article

Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

2023-02-02

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma (LUAD) is an extraordinarily malignant tumor, with rapidly increasing morbidity and poor prognosis. Immunotherapy has emerged as a hopeful therapeutic modality for lung adenocarcinoma. Furthermore, a prognostic model (based on immune genes) can fulfill the purpose of early diagnosis and accurate prognostic prediction. <h4>Methods: </h4>: Immune-related mRNAs (IRmRNAs) wer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9615fbce-0e2d-5a28-af2d-6eb38d794fa9
DOI
10.21203/rs.3.rs-2520613/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patientsDOI 10.21203/rs.3.rs-2520613/v1
Select a neighboring publication to make it the new centre.